— Relieves the oral symptoms associated with dry mouth–
CLAREMONT, Calif. – September 25, 2018– Prisyna, the oral care division of Synedgen, founded to optimize oral health using advanced, proprietary glycomics technology, today announced the market launch of Moisyn Rinse for the relief of xerostomia.
Xerostomia (also known as dry mouth, or dry mouth syndrome) occurs when there is a decrease in the presence of saliva. Dry mouth affects a large percentage of the adult population, and as much as half of the elderly population in the United States. The symptoms of dry mouth significantly impact patient quality of life and often cause difficulty in chewing, swallowing and speaking. Xerostomia can result in dry, thick oral mucus, painful oral tissues, bad breath, and sleep disturbance.
Moisyn Rinse is the follow-up companion product to Moisyn Mist, Prisyna’s convenient dry mouth spray. The Moisyn product line is the first glycomics targeted therapy that has been shown in a clinical study to reduce pain and increase comfort for patients living with dry mouth.1 Moisyn products relieve the symptoms of dry mouth while moisturizing and lubricating oral dryness.
“The launch of Moisyn Rinse is another great milestone for Prisyna and our dedicated team. I believe our technology is truly unique, innovative, and most importantly, addresses a need that is not currently being fully met with the product offerings on the market. Prisyna’s advanced, patented technology provides relief that soothes dry mouth symptoms,” said Leo Pranitis, General Manager of Prisyna. “We are now pleased to offer patients dry mouth relief in both a rinse and spray form.”
“It’s exciting to see our product line expand to include the Moisyn Rinse, said Dr. Shenda Baker, COO of Synedgen. “The value of Moisyn to patients reflects the benefit of our core glycomic science in addressing important medical challenges. Prisyna is the first of our divisions to become commercially viable, and we look forward to bringing our innovations to other areas of medicine where acute needs still exist.”
1Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jan;123(1):76-83. doi: 10.1016/j.oooo.2016.09.008. Epub 2016 Sep 28.
About Xerostomia (Dry Mouth)
Xerostomia, or dry mouth, causes dryness in the oral cavity, most commonly the tongue and roof of the mouth. Typically, it is identified by a reduction or absence of oral saliva and can be brought on by a variety of conditions, including aging. Over 1000 prescription and non-prescription medications, including drugs for treating anxiety, depression, high blood pressure, allergies, and cancer are known to alter the production of saliva and cause dry mouth as a side effect.
Common problems stemming from dry mouth include tooth decay, disturbed sleep, dry throat, burning sensation in the throat, gum disease, oral infections, taste change, and difficulty speaking and swallowing.